Buy Crypto Markets Spot FuturesGOLD Earn Event Center

TriSalus Life Sciences, Inc. (TLSI)

NASDAQ

$2.68

$+0.21

(+8.33%)

TriSalus Life Sciences, Inc. (TLSI) Live Price Chart

Page last updated: 2026-05-15 21:02:00

Key Market Data

Market Cap	$164.71M
Open	$2.48
High	$16.24
Low	$2.20
Previous Close	$2.52
Price Change	$+0.21
Percentage Change	+8.33%
Volume	2M

TriSalus Life Sciences, Inc. (TLSI) Stock Price Today

TriSalus Life Sciences, Inc. (TLSI) is currently trading at $2.68 as of 2026-05-15 21:02:00, reflecting a +8.33% move ($+0.21) from the previous close.

In the short term, the stock has returned -40.27% over the past four weeks. Over the last 12 months, TriSalus Life Sciences, Inc. has recorded a -47.51% price change, indicating a Weak performance relative to the broader market.

TriSalus Life Sciences, Inc. (TLSI) 7-Day Stock Price Changes

Over the past seven days, TriSalus Life Sciences, Inc. has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $4.45 to the latest recorded price of $2.68, reflecting an intraday change of +8.33%. Daily movements highlight shifts in trading volume (2,128,596), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TLSI has delivered a -40.27% return over the past month and a -47.51% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy TriSalus Life Sciences, Inc. (TLSI)

You can buy and trade TLSI on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TLSI and Execute Your Trade

Open the trading page, enter TLSI in the search bar, select the amount of TLSI you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is TriSalus Life Sciences, Inc. (TLSI)?

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

TriSalus Life Sciences, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	102
Sector	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website	https://www.trisaluslifesci.com

Frequently Asked Questions (FAQ)

1.What is the current share price of TriSalus Life Sciences, Inc.?

The latest trading price for TriSalus Life Sciences, Inc. (Common Stock) is $ 2.68, compared with a previous closing price of $ 2.52. That means the stock has moved +8.33% so far today. Intraday price updates and recent trading activity for TLSI can be tracked on the live chart and quote section on this page.

2.Is TriSalus Life Sciences, Inc. stock going up or down?

Looking at recent performances, TLSI has returned -40.27% over the past month, -40.13% over the last six months and -47.51% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for TriSalus Life Sciences, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does TLSI currently sit relative to its 52-week high and low?

In the most recent 52-week period, TriSalus Life Sciences, Inc. has traded between a low of $ 2.20 and a high of $ 7.95. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether TLSI is currently nearer the top or the bottom of its one-year trading band.

4.How is TriSalus Life Sciences, Inc. classified by sector and industry?

TriSalus Life Sciences, Inc. is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. In practice, this means TriSalus Life Sciences, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing TLSI’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector could influence TriSalus Life Sciences, Inc.’s performance.

5.Where is TriSalus Life Sciences, Inc. listed and how large is it by market value?

TriSalus Life Sciences, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 164.71M, the company is classified as a Small-cap stock. Market cap gives a quick sense of TriSalus Life Sciences, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does TLSI's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.95 summarises how much profit TriSalus Life Sciences, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track TriSalus Life Sciences, Inc.'s financial performance over time?

To follow TriSalus Life Sciences, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TLSI is performing and how the market is responding.

8.When is TriSalus Life Sciences, Inc. expected to report earnings?

TriSalus Life Sciences, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TLSI, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in TriSalus Life Sciences, Inc.'s earnings reports?

TriSalus Life Sciences, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TLSI is meeting, beating or missing expectations.

10.How can I stay informed about TriSalus Life Sciences, Inc.'s results and guidance?

You can stay up to date on TriSalus Life Sciences, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TLSI on this page helps you see how new information is being reflected in the stock.

11.Does TriSalus Life Sciences, Inc. pay a regular cash dividend to its shareholders?

TriSalus Life Sciences, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TLSI's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TLSI?

Based on the latest earnings data, TLSI has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether TriSalus Life Sciences, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings TriSalus Life Sciences, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is TriSalus Life Sciences, Inc.?

TriSalus Life Sciences, Inc. is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TLSI valued in terms of P/E ratio and EPS?

TriSalus Life Sciences, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.95. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of TriSalus Life Sciences, Inc.'s earnings. Comparing TLSI's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

HCW Biologics Inc.

HCWB

3 E Network Technology Group Ltd

MASK

Fitness Champs Holdings Limited

FCHL

Cheer Holding, Inc.

CHR

Silexion Therapeutics Corp.

SLXN

Top Gainers

Browse today's leading gainers in the US stock market

HCW Biologics Inc.

HCWB

P3 Health Partners Inc.

PIII

Murano Global Investments PLC

MRNO

Auddia Inc.

AUUD

Super League Enterprise, Inc.

SLE

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

TLSI-to-USD Calculator

Amount

TLSI

USD

1 TLSI = 2.682 USD